Maiwald at LSPN North America Spring 2026 in Boston | April 29th-30th

Maiwald will once again participate in the most influential IP conference for the life sciences this year.

The annual LSPN Spring conference in Boston is a key meeting point for cutting-edge insights into IP challenges across the pharmaceutical, biotechnology, and medical device industries. We are therefore delighted to attend, and that Dr. Eva Ehlich—just like last year—will again be speaking and moderating an engaging panel discussion.

At a time when the life sciences IP landscape is evolving rapidly, this leading conference brings together top innovators and thought leaders to discuss strategic IP protection—from advanced therapies to market dominance. The program features 20+ high-impact sessions on patent developments across the Americas, Europe, and Asia, as well as targeted networking opportunities with more than 350 senior decision-makers.

We look forward to insightful discussions on litigation, prosecution, and commercialization strategies, and to exchanging views on the trends shaping the life sciences IP landscape.